[SCHEDULE 14A INFORMATION Check the appropriate box: ☒ Preliminary Proxy Statement ☐ ☐ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Cleantech Solutions International, Inc. N.A. Payment of Filing Fee (Check the appropriate box): ☒ No fee required. ☐ Fee computed on table below per Ex]
[The9 Limited to Hold Annual General Meeting on December 4, 2017 Shanghai China, November 3, 2017 No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will serve as an open forum for shareholders of record and beneficial owners of t]
[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) THIRD QUARTERLY REPORT FOR 2017 The financial information set out in this quarterly report has not been audited, and has been prepared in accordance with the PRC Enterprise Accounting Standards. 1. IMP]
[The9 Limited to Hold Annual General Meeting on December 4, 2017 Shanghai China, November 3, 2017 No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will serve as an open forum for shareholders of record and beneficial owners of t]
[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) THIRD QUARTERLY REPORT FOR 2017 The financial information set out in this quarterly report has not been audited, and has been prepared in accordance with the PRC Enterprise Accounting Standards. 1. IMP]
[Number 1.1 Circular regarding proposed amendments to Articles of Association and notice of extraordinary general meeting, dated November 3, 2017 6-K our business and operating strategies and our ability to successfully execute these strategies; our network expansion and capital expenditure plans]
[Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq BEIJING, November 3, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(”Sinovac”), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017, the Company received a delisti]
[Number 1.1 Circular regarding proposed amendments to Articles of Association and notice of extraordinary general meeting, dated November 3, 2017 6-K our business and operating strategies and our ability to successfully execute these strategies; our network expansion and capital expenditure plans]
[Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq BEIJING, November 3, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(”Sinovac”), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017, the Company received a delisti]
